308 related articles for article (PubMed ID: 35137398)
21. Ferret Lung Transplantation Models Differential Lymphoid Aggregate Morphology Between Restrictive and Obstructive Forms of Chronic Lung Allograft Dysfunction.
Lynch TJ; Ahlers BA; Swatek AM; Ievlev V; Pai AC; Brooks L; Tang Y; Evans IA; Meyerholz DK; Engelhardt JF; Parekh KR
Transplantation; 2022 Oct; 106(10):1974-1989. PubMed ID: 35442232
[TBL] [Abstract][Full Text] [Related]
22. Bronchoalveolar lavage cytokine-based risk stratification of minimal acute rejection in clinically stable lung transplant recipients.
Levy L; Huszti E; Ahmed M; Ghany R; Hunter S; Moshkelgosha S; Zhang CYK; Boonstra K; Klement W; Tikkanen J; Singer LG; Keshavjee S; Juvet S; Martinu T
J Heart Lung Transplant; 2021 Dec; 40(12):1540-1549. PubMed ID: 34215500
[TBL] [Abstract][Full Text] [Related]
23. Epithelial and Erythrocyte Microvesicles From Bronchoalveolar Lavage Fluid Are Elevated and Associated With Outcome in Chronic Lung Allograft Dysfunction.
Harms A; Fuehner T; Warnecke G; Haverich A; Gottlieb J; Trummer A
Transplantation; 2015 Nov; 99(11):2394-400. PubMed ID: 26451527
[TBL] [Abstract][Full Text] [Related]
24. Restrictive allograft syndrome (RAS): a novel form of chronic lung allograft dysfunction.
Sato M; Waddell TK; Wagnetz U; Roberts HC; Hwang DM; Haroon A; Wagnetz D; Chaparro C; Singer LG; Hutcheon MA; Keshavjee S
J Heart Lung Transplant; 2011 Jul; 30(7):735-42. PubMed ID: 21419659
[TBL] [Abstract][Full Text] [Related]
25. Systems prediction of chronic lung allograft dysfunction: Results and perspectives from the Cohort of Lung Transplantation and Systems prediction of Chronic Lung Allograft Dysfunction cohorts.
Pison C; Tissot A; Bernasconi E; Royer PJ; Roux A; Koutsokera A; Coiffard B; Renaud-Picard B; Le Pavec J; Mordant P; Demant X; Villeneuve T; Mornex JF; Nemska S; Frossard N; Brugière O; Siroux V; Marsland BJ; Foureau A; Botturi K; Durand E; Pellet J; Danger R; Auffray C; Brouard S; Nicod L; Magnan A;
Front Med (Lausanne); 2023; 10():1126697. PubMed ID: 36968829
[TBL] [Abstract][Full Text] [Related]
26. The Lung Microbiome Predicts Mortality and Response to Azithromycin in Lung Transplant Recipients with Chronic Rejection.
Combs MP; Luth JE; Falkowski NR; Wheeler DS; Walker NM; Erb-Downward JR; Wakeam E; Sjoding MW; Dunlap DG; Admon AJ; Dickson RP; Lama VN
Am J Respir Crit Care Med; 2024 Jun; 209(11):1360-1375. PubMed ID: 38271553
[No Abstract] [Full Text] [Related]
27. Chronic lung allograft dysfunction phenotype and prognosis by machine learning CT analysis.
McInnis MC; Ma J; Karur GR; Houbois C; Levy L; Havlin J; Fuchs E; Tikkanen J; Chow CW; Huszti E; Martinu T
Eur Respir J; 2022 Jul; 60(1):. PubMed ID: 34949699
[TBL] [Abstract][Full Text] [Related]
28. Macrophage and CD8 T cell discordance are associated with acute lung allograft dysfunction progression.
Calabrese DR; Ekstrand CA; Yellamilli S; Singer JP; Hays SR; Leard LE; Shah RJ; Venado A; Kolaitis NA; Perez A; Combes A; Greenland JR
J Heart Lung Transplant; 2024 Jul; 43(7):1074-1086. PubMed ID: 38367738
[TBL] [Abstract][Full Text] [Related]
29. CT at onset of chronic lung allograft dysfunction in lung transplant patients predicts development of the restrictive phenotype and survival.
Dettmer S; Shin HO; Vogel-Claussen J; Westphal M; Haverich A; Warnecke G; Welte T; Wacker F; Gottlieb J; Suhling H
Eur J Radiol; 2017 Sep; 94():78-84. PubMed ID: 28647206
[TBL] [Abstract][Full Text] [Related]
30. Interferon-stimulated and metallothionein-expressing macrophages are associated with acute and chronic allograft dysfunction after lung transplantation.
Moshkelgosha S; Duong A; Wilson G; Andrews T; Berra G; Renaud-Picard B; Liu M; Keshavjee S; MacParland S; Yeung J; Martinu T; Juvet S
J Heart Lung Transplant; 2022 Nov; 41(11):1556-1569. PubMed ID: 35691795
[TBL] [Abstract][Full Text] [Related]
31. Relation of sputum neutrophilia to the development of chronic lung allograft dysfunction after lung transplantation.
Sikkeland LIB; Durheim MT; Riste TB; Kongerud J; Alexis NE; Holm AM
Clin Transplant; 2021 Mar; 35(3):e14188. PubMed ID: 33315265
[TBL] [Abstract][Full Text] [Related]
32. Chronic Lung Allograft Dysfunction.
Venado A; Kukreja J; Greenland JR
Thorac Surg Clin; 2022 May; 32(2):231-242. PubMed ID: 35512941
[TBL] [Abstract][Full Text] [Related]
33. Impact of chronic lung allograft dysfunction, especially restrictive allograft syndrome, on the survival after living-donor lobar lung transplantation compared with cadaveric lung transplantation in adults: a single-center experience.
Sugimoto S; Yamamoto H; Kurosaki T; Otani S; Okazaki M; Yamane M; Toyooka S; Oto T
Surg Today; 2019 Aug; 49(8):686-693. PubMed ID: 30790054
[TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of early pulmonary function changes after onset of chronic lung allograft dysfunction.
Todd JL; Neely ML; Finlen Copeland CA; Frankel CW; Reynolds JM; Palmer SM
J Heart Lung Transplant; 2019 Feb; 38(2):184-193. PubMed ID: 30466803
[TBL] [Abstract][Full Text] [Related]
35. Chronic Lung Allograft Dysfunction: Evolving Concepts and Therapies.
DerHovanessian A; Wallace WD; Lynch JP; Belperio JA; Weigt SS
Semin Respir Crit Care Med; 2018 Apr; 39(2):155-171. PubMed ID: 29579768
[TBL] [Abstract][Full Text] [Related]
36. Gene Expression Profiling of Bronchoalveolar Lavage Cells Preceding a Clinical Diagnosis of Chronic Lung Allograft Dysfunction.
Weigt SS; Wang X; Palchevskiy V; Gregson AL; Patel N; DerHovanessian A; Shino MY; Sayah DM; Birjandi S; Lynch JP; Saggar R; Ardehali A; Ross DJ; Palmer SM; Elashoff D; Belperio JA
PLoS One; 2017; 12(1):e0169894. PubMed ID: 28103284
[TBL] [Abstract][Full Text] [Related]
37. Elucidating immune cell dynamics in chronic lung allograft dysfunction: A comprehensive single-cell transcriptomic study.
Bai Y; Di L; Liu W; Zhou F; Ma J; Meng G; Li M; Sun G
Comput Biol Med; 2024 May; 173():108254. PubMed ID: 38520924
[TBL] [Abstract][Full Text] [Related]
38. Montelukast in chronic lung allograft dysfunction after lung transplantation.
Vos R; Eynde RV; Ruttens D; Verleden SE; Vanaudenaerde BM; Dupont LJ; Yserbyt J; Verbeken EK; Neyrinck AP; Van Raemdonck DE; Verleden GM;
J Heart Lung Transplant; 2019 May; 38(5):516-527. PubMed ID: 30638839
[TBL] [Abstract][Full Text] [Related]
39. Therapy options for chronic lung allograft dysfunction-bronchiolitis obliterans syndrome following first-line immunosuppressive strategies: A systematic review.
Benden C; Haughton M; Leonard S; Huber LC
J Heart Lung Transplant; 2017 Sep; 36(9):921-933. PubMed ID: 28662986
[TBL] [Abstract][Full Text] [Related]
40. Incidence and impact of chronic lung allograft dysfunction after lung transplantation - single-center 14-year experience.
Nykänen A; Raivio P; Peräkylä L; Stark C; Huuskonen A; Lemström K; Halme M; Hämmäinen P
Scand Cardiovasc J; 2020 Jun; 54(3):192-199. PubMed ID: 32148103
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
